EnVVeno Medical Highlights Successful 2024 VEITH Symposium With Launch of Recap Website

Accesswire11/27 21:30

NVNO Completes Application for VenoValve's PMA, Shares Likely to Gain

Zacks 11/25 21:35

EnVVeno Medical To Present Data From VenoValve Trial At 51st Annual VEITH Symposium; Data Includes Showing 85% Clinical Meaningful Benefit Responder Rate, 87% Median Ulcer Area Reduction

Benzinga11/20 21:33

EnVVeno Medical to Present Definitive One Year Data From the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium

Accesswire11/20 21:30

EnVVeno Medical Submits PMA Application To FDA To Sell And Market VenoValve In The US

Benzinga11/19 21:17

EnVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval

Accesswire11/19 21:15